| |
Brief Excerpt: | Fitch Ratings: Pricing Offsets Upbeat Secular Trends in Global Pharma 19 Oct 2018 1:37 PM (EDT) Link to Fitch Ratings' Report(s): Global Pharma and Biotech aÇô What Investors Want to Know {COMPANYDESC_ORIGIN_PUBDATE}: Underlying trends... |
| |
Report Type: | |
Company(ies) | Pfizer Inc.
, AstraZeneca PLC
, GSK PLC
, Novartis AG
, Sanofi SA
, Eli Lilly and Company
, Johnson & Johnson
, Roche Holding AG
, Bayer AG
, Teva Pharmaceutical Industries Ltd.
, ALLERGAN UNLIMITED COMPANY
, Teva Pharmaceuticals USA Inc.
, Glaxosmithkline Capital Plc
, Novartis Finance S.A.
, Utah Acquisition Sub Inc
, Novartis Securities Investment Limited
, Novartis Capital Corporation
, Glaxosmithkline Capital Inc. |
Ticker(s) | AZN
, BAYN
, GSK
, JNJ
, LLY
, NOT
, PFE
, RO
, SAN
, TEVA |
Issuer | Utah Acquisition Sub Inc. |
Format: | HTML |  |
|
| |